Dr Reddys Laboratories Share Price Today - Live Blog for May 02, 2025

Dr Reddys Laboratories Ltd's shares saw an increase of 0.01%, reaching the current market price of ₹1,181.75. This development underscores the stock's growing popularity.

Dr Reddys Laboratories Ltd witnessed a -0.03% decrease in its share price, and it is currently trading at ₹1,182.90. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.3800, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Demonstrating a commendable 0.30% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,182.60. In terms of valuation, the stock maintains a PE ratio of 18.3800, while the industry PE ratio stands at 34.5709.

With a remarkable 0.11% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,179.35. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3800, while the industry's PE ratio is 34.5709.

With a -0.78% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,176.95. Investors should examine the factors driving this decline. The stock's PE ratio is 18.3800, whereas the industry PE ratio stands at 34.5709.

Dr Reddys Laboratories Ltd share price has declined by -0.11%, and it's currently trading at ₹1,186.25. The stock maintains a PE of 18.3800, while the industry PE is 34.5709, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 0.11%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,187.50 per share.

With a remarkable 0.07% increase in value, the share price of Dr Reddys Laboratories Ltd currently stands at ₹1,186.20. Notably, this stock has a Price-to-Earnings (PE) ratio of 18.3800, while the industry's PE ratio is 34.5709.

The stock price of Dr Reddys Laboratories Ltd enjoyed a significant 0.48% boost, with the current market value at ₹1,184.00 per share. This surge has not gone unnoticed by investors.

Climbing steadily, Dr Reddys Laboratories Ltd shares have ascended by 0.26%, reaching the current market price of ₹1,178.35. This ascent signifies increased investor sentiment. The stock has an ROE of 17.3623% and debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd is making significant strides, boasting a 0.14% increase and currently trading at ₹1,176.30 per share. This upward trajectory is turning heads in the market.

Dr Reddys Laboratories Ltd witnessed a substantial 0.12% increase in its share price and is currently trading at ₹1,175.50. This remarkable performance has caught the eye of investors.

Dr Reddys Laboratories Ltd share price has declined by -0.28%, and it's currently trading at ₹1,174.10. The stock maintains a PE of 18.3800, while the industry PE is 34.5709, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd share price has declined by -0.14%, and it's currently trading at ₹1,178.55. The stock maintains a PE of 18.3800, while the industry PE is 34.5709, prompting discussions about its valuation.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.38% recently. As of now, this stock is actively trading at a current market price of ₹1,178.75 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd's stock has surged by 0.05%, and it is currently trading at ₹1,174.30. Additionally, the stock maintains a PE ratio of 18.3800, while the industry PE is 34.5709.

Dr Reddys Laboratories Ltd's share price has fallen by -0.04%, a situation worth noting. At present, the stock is trading at ₹1,173.40. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.3800, while the industry PE ratio is 34.5709.

The stock of Dr Reddys Laboratories Ltd is facing a -0.53% decline and is currently trading at ₹1,173.75 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

The share price of Dr Reddys Laboratories Ltd plunged by -0.31%, leaving investors concerned. At this moment, the stock can be acquired at ₹1,180.00, but investors are assessing whether this is a temporary dip or a long-term trend.

The stock of Dr Reddys Laboratories Ltd suffered a -0.61% drop, and it's now trading at ₹1,185.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's share price has dropped by -0.23%, a development that warrants careful analysis. Presently trading at ₹1,189.65, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd's share price has dropped by -0.18%, a development that warrants careful analysis. Presently trading at ₹1,191.75, investors are assessing whether this presents an opportunity or a risk.

Dr Reddys Laboratories Ltd has had quite the run lately, experiencing a substantial 0.14% uptick in its share price. As a result, it's now actively trading at ₹1,193.00 per share, making it an attractive option for investors.

Dr Reddys Laboratories Ltd observed a remarkable 0.65% surge in its share price and is presently trading at ₹1,190.75. The increased investor interest is driving this surge.

The share price of Dr Reddys Laboratories Ltd experienced an impressive 0.40% upswing and is currently trading at ₹1,183.05, indicating strong market sentiment.

Dr Reddys Laboratories Ltd share price has declined by -1.93%, and it's currently trading at ₹1,176.80. The stock maintains a PE of 18.3800, while the industry PE is 34.5709, prompting discussions about its valuation.